Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,4412,460 of 20,252 grants

Active RESEARCH CENTERS
Administrative and Engagement Core
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Nigeria is at a crossroads in its cancer control response. On the one hand, the country remains an epicenter of a growing cancer crisis. On the other hand, there are existing guide...

Active RESEARCH CENTERS
Research and Capacity Building Core
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Nigeria, Africa’s most populous country, bears the second highest burden of cancer cases (11%) and deaths (12%) in Africa.1 Evidence-based cancer control interventions such as vacc...

Active RESEARCH CENTERS
Research Project 1
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

1 Nigerians make up a significant proportion of individuals in Africa dying from human papillomavirus-(HPV) 2 associated cancers. However, they do not access essential cancer preve...

Active RESEARCH CENTERS
Research Project 2
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Every hour, over 150 people die of hepatitis-related liver diseases in African countries like Nigeria, including hepatocellular carcinoma (HCC) and other liver cancers. Much of thi...

Active RESEARCH CENTERS
Research Education Core
NATIONAL CANCER INSTITUTE San Diego State University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT – RESEARCH EDUCATION CORE The goal of the Cancer Research and Education to Advance HealTh Equity (CREATE) Research Education (RE) Core is to provide critic...

Completed SBIR-STTR RPGS
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
NATIONAL CANCER INSTITUTE 7 Hills Pharma, Llc United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Immuno-oncology (IO) therapies, particularly immune checkpoint inhibitors (ICIs) such as nivolumab (anti-PD- 1) and ipilimumab (anti-CTLA-4) have made rapi...

$9.99M
USD
Active RESEARCH CENTERS
Outreach Core
NATIONAL CANCER INSTITUTE San Diego State University United States 2023 – 2028

PROJECT SUMMARY/ ABSTRACT – OUTREACH CORE The Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership’s geographic area is composed of San Diego and Imperial Co...

Active NON-SBIR/STTR RPGS
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Project Summary/Abstract The prognosis for pancreatic ductal adenocarcinomas (PDAC) patients is dismal. Unfortunately, attempts at immunotherapy for PDAC to date using single agent...

$6.12M
USD
Active RESEARCH CENTERS
Center for Cancer Systems Therapeutics (CaST)
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus derivin...

$17.36M
USD
Completed OTHER RESEARCH-RELATED
Ferroptosis in drug resistant glioma
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2025

Project Abstract Cancer drug resistance is the last frontier in extending patient overall survival, especially in the deadly brain tumor – glioblastoma (GBM). GBM currently has one...

$1.29M
USD
Active NON-SBIR/STTR RPGS
Molecular Mechanisms by which Statins Prevent and Reverse Hepatocellular Carcinoma
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2027

Project Summary/Abstract Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. HMG-CoA reductase (HMGCR) inhibitors, statins, show high potential...

$3.12M
USD
Active NON-SBIR/STTR RPGS
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
NATIONAL CANCER INSTITUTE Henry Ford Health + Michigan State Unive... United States 2023 – 2028

Abstract It became well known that the immune suppressive niche inside the tumor microenvironment (TME) accounts for tumor immune escape and progression, in which the regulatory T...

$6.02M
USD
Active OTHER RESEARCH-RELATED
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
NATIONAL CANCER INSTITUTE Kenya Medical Research Institute (Kemri Kenya 2023 – 2027

KEMRI-PHRD CLINICAL TRIAL SITE FOR CASCADE NETWORK ‘CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV Project Summary/Abstract: Cervical cancer is the leading cause of cancer-re...

$3.33M
USD
Active NON-SBIR/STTR RPGS
Development of contrast agents to facilitate image-guided surgery
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2023 – 2028

Presently, surgical resection offers the only chance of cure for patients with pancreatic adenocarcinoma. While the goal of resection is to obtain R0 (negative) margins, the report...

$5.64M
USD
Active NON-SBIR/STTR RPGS
Multi-cancer early detection using cell-free DNA methylome analysis
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2028

PROJECT SUMMARY Detecting cancer early is the best way to fight against cancer. The development of the Multi-Cancer Early Detection (MCED) liquid biopsy tests holds great promise f...

$8.79M
USD
Active NON-SBIR/STTR RPGS
Clinical Translation of dual-modality transrectal ultrasound and photoacoustic imaging for detection of aggressive human prostate cancer
NATIONAL CANCER INSTITUTE Pennsylvania State University, The United States 2023 – 2028

ABSTRACT Prostate cancer (PCa), with an annually increasing incident rate, has become the most commonly diagnosed cancer in American men. The accurate diagnosis of aggressive PCa i...

$5.88M
USD
Active RESEARCH CENTERS
Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

CENTER OVERALL: PROGRAM SUMMARY / ABSTRACT While considerable evidence is available for screening and early treatment of breast and cervical cancers, huge gaps remain in equitable...

$9.23M
USD
Active RESEARCH CENTERS
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

CENTER OVERALL: PROGRAM SUMMARY / ABSTRACT While considerable evidence is available for screening and early treatment of breast and cervical cancers, huge gaps remain in equitable...

Completed NON-SBIR/STTR RPGS
Germline Genetic Modifiers of Radiation Response
NATIONAL CANCER INSTITUTE Sri International United States 2023 – 2025

Approximately 50% of cancer patients receiving ionizing radiation suffer from radiation-induced normal tissue injury that significantly affects quality of life and presents potenti...

$4.01M
USD
Active RESEARCH CENTERS
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

CENTER OVERALL: PROGRAM SUMMARY / ABSTRACT While considerable evidence is available for screening and early treatment of breast and cervical cancers, huge gaps remain in equitable...